We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




High-Volume Microplate Designed for Sensitive Photometric Assays

By LabMedica International staff writers
Posted on 02 Dec 2009
With a well volume of 3.1 mL, a new microplate is a suitable choice for screening applications that require high sensitivity combined with photometric accuracy and repeatability. More...
Moreover, the microplate's large surface area per well makes the tissue culture-treated version of the plate ideal for cell growth applications.

Constructed in ultra-pure grade polystyrene, Krystal 24 microplates, developed by Porvair Sciences, Ltd. (Leatherhead, Surrey UK), are available in opaque white and solid black formats. For sensitive fluorescence measurements, the black plate provides the all-absorbing background needed to minimize background interference. The opaque white plate maximizes reflectivity enabling even weakly emitting luminescence assays to be routinely undertaken. In addition to optimized luminescence and fluorescence measurements, the unique Krystal 24 design offers improved cell binding efficiency and provides the convenience of direct measurements on bottom reading spectrophotometers and inverted microscopes.

Precisely manufactured to SBS/ANSI microplate dimensions, the cost-effective Krystal 24 design is fully compatible with all commercially available plate readers, robotic sample processors, and automated liquid-handling systems. (ANSI/SBS 1-2004 Microplate Footprint Dimensions as registered and designated by the American National Standards Institute [ANSI]).

Porvair Sciences' expertise in microplate technology and manufacturing covers scientific fields including life sciences, drug discovery, combinatorial chemistry, solid phase extraction, protein purification, high-throughput screening, proteomics and genomics. Porvair Sciences is a wholly owned subsidiary of Porvair plc.

Related Links:
Porvair Sciences



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.